Dr. Wong will discuss how organization of immune ligands impacts immune activation via Toll-Like Receptors, the surprising role played by innate immunity peptides in this organization, and how these effects are at play in inflammation induced by heart disease, necrotic cell death, neutrophil extracellular traps, and autoimmune diseases.
BO WANG, DEPARTMENT OF BIOENGINEERING and JIAN QIN, DEPARTMENT OF CHEMICAL ENGINEERING
Attend Dr. Wang's and Dr. Qin's pre-seminar presentation to learn more about Dr. Gerard Wong's seminar, "Physical chemistry and machine learning meet innate immunity", to be held Thursday, March 9th.
MELODY SWARTZ, UNIVERSITY OF CHICAGO
It has long been assumed that local lymph formation is driven primarily by pressure gradients generated by interstitial fluid stress and downstream lymphatic pump function, but Dr. Swartz's lab has found that vesicular transendothelial transport also contributes significantly to lymph formation and is actively regulated by the lymphatic endothelium according to inflammatory stimuli, allowing fine control of the delivery of antigens, cells, and chemokines to the local lymph node.
ANNELISE BARRON, DEPARTMENT OF BIOENGINEERING
Attend Dr. Barron's pre-seminar presentation to learn more about Dr. Melody Swartz's seminar, "Lymphatic vessels in inflammation and cancer: Linking mechanobiology with immune regulation", to be held Thursday, February 16th.
SAMUEL STUPP, NORTHWESTERN UNIVERSITY
Dr. Stupp's lecture will demonstrate the use of supramolecular biomaterials in regeneration of the spinal cord, cartilage, bone, muscle, and blood vessels, among others; and will also describe the possibility of using these systems dynamically to turn signals to cells "on and off" reversibly, a direction which may prove useful in the management of stem cells in regenerative medicine.
HELEN BLAU, DEPARTMENT OF MICROBIOLOGY & IMMUNOLOGY
Attend Dr. Blau's pre-seminar presentation to learn more about Dr. Samuel Stupp's seminar, "Guiding BioRegeneration with Supramolecular Materials", to be held Thursday, January 19th.
BRETT BOUMA, HARVARD MEDICAL SCHOOL AND MASSACHUSETTS GENERAL HOSPITAL
Optical coherence tomography, an imaging modality based on interferometric detection of backscattered infrared light, was initially demonstrated in 1991. The technical advances as well as the hurdles that underpin the long development timeline of OCT will be discussed and the current clinical status will be reviewed.
AUDREY BOWDEN, DEPARTMENT OF ELECTRICAL ENGINEERING
Attend Dr. Bowden's pre-seminar presentation to learn more about Dr. Brett Bouma's seminar, "The development of optical coherence tomography as a medical device", to be held Thursday, December 8th.
MOLLY SHOICHET, UNIVERSITY OF TORONTO
The Shoichet lab's research program requires a cross disciplinary approach where aspects of engineering, chemistry, and biology are applied to the fields of Regenerative Medicine, Tissue Engineering and Drug Delivery. They have become very interested in drug discovery, drug screening and drug delivery in cancer.
FAN YANG, DEPARTMENTS OF ORTHOPAEDIC SURGERY AND OF BIOENGINEERING
Attend Dr. Yang's pre-seminar presentation to learn more about Dr. Molly Shoichet's seminar, "3 cancer stories – from colloidal drug aggregates to 3D cell culture to targeted delivery", to be held Thursday, November 3rd.
